TAMMY FULLER: Open Payments
NPI 1619614930 · NEW SMYRNA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$881 in 35 payments from 16 companies in 2025. Trend: 2023 $894 · 2024 $1,212 · 2025 $881
Food & beverage: $881
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 2 | $175 |
| Alnylam Pharmaceuticals Inc. | 4 | $92 |
| Amgen Inc. | 5 | $91 |
| Novartis Pharmaceuticals Corporation | 5 | $89 |
| BridgeBio Pharma, Inc. | 3 | $73 |
| E.R. Squibb & Sons, L.L.C. | 3 | $60 |
| Novo Nordisk Inc | 2 | $51 |
| MicroTransponder, Inc. | 1 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| PFIZER INC. | 2 | $33 |
Products named: Barostim Neo System, ONPATTRO, REPATHA, LEQVIO, Attruby, CAMZYOS, Wegovy, ELIQUIS.
Industry payments across FL — which companies pay providers there.
